Irinophore C™, a lipid-based nanoparticulate formulation of irinotecan, is more effective than free irinotecan when used to treat an orthotopic glioblastoma model - Verreault, M.; Strutt, D.; Masin, D.; Anantha, M.; Waterhouse, D.; Yapp, D.T.; Bally, M.B. (Journal of Controlled Release, 2012)